This bonus section provides insights into a promising area for mental health.

Psychedelics, such as MDMA and psilocybin, are a class of psychoactive substances that produce changes in perception, mood, and cognitive processes. They have shown promise in treating mental health conditions, including anxiety and depression:

- MDMA: Also known as "ecstasy" or "molly", MDMA has been approved for use in treating post-traumatic stress disorder (PTSD). It works by encouraging the growth of new connections between neurons in the brain.

- Psilocybin: Found in "magic" mushrooms, psilocybin has been approved for use in treating treatment-resistant depression. Like MDMA, it also promotes the growth of new neural connections.

- Opioids: While not traditionally classified as psychedelics, certain opioids have been explored for their potential in treating mental health disorders. However, their use is controversial due to the risk of addiction and other serious side effects.

These substances are only approved for use under controlled medical settings by authorised psychiatrists. While they offer hope for those who have not found relief from other treatments, experts stress the need for more research into their long-term effects.

In this section you have access to the latest research into MDMA, Psilocybin and Opioids.